Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction

Clinical trial NCT04798430 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT04798430
Sponsor: LIB Therapeutics LLC
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease With Mention of Arteriosclerosis Elevated Cholesterol Familial Hypercholesterolemia

Start date: 2020-12-03
Primary completion: 2025-07-30
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.